The Synedica Retatrutide 40mg + KLOW Skin 80mg Bundle brings together two Synedica formulations presented in pen format for laboratory research.

Bundle Includes

1 × Synedica Retatrutide 40mg Pen

Retatrutide is described on the product packaging as a triple agonist of GLP-1, GIP and glucagon receptors.

The packaging displays a total labelled content of 40mg, supplied as 4 × 10mg doses. Each box contains one pen, 12 disposable needles, and one instruction book.

1 × Synedica KLOW Skin 80mg Pen

The KLOW Skin formulation contains:

• GHK-Cu — 48mg
• BPC-157 — 10mg
• TB-500 — 10mg
• KPV — 10mg
• Vitamin B12 — 2mg

The packaging displays a total labelled content of 80mg and states that the box contains one pen, 12 disposable needles, and one instruction booklet.

Combined Bundle Content

• Synedica Retatrutide — 40mg
• Synedica KLOW Skin — 80mg
• 120mg combined labelled content

Both products are supplied in pen format.

Key Features

• Synedica research bundle
• 1 × Retatrutide 40mg Pen
• 1 × KLOW Skin 80mg Pen
• 120mg combined labelled content
• KLOW contains GHK-Cu, BPC-157, TB-500, KPV & Vitamin B12
• Retatrutide research formulation
• Convenient two-product research bundle
• Pen-format formulations
• 12 disposable needles included with each product according to packaging
• Instruction booklet included with each product

How to Use (Research Reference Only)

These products are intended exclusively for laboratory and scientific research conducted by qualified professionals using appropriate research protocols.

Experimental handling, preparation, storage, and application should follow relevant laboratory procedures and institutional requirements.

Not intended for human consumption or self-administration.

Research Applications

The individual formulations may be investigated in research involving:

• Metabolic signalling
• GLP-1, GIP and glucagon receptor pathways
• Peptide-receptor interactions
• Cellular signalling
• Skin and tissue biology
• Molecular and biochemical pathways
• Multi-component peptide research

Research Disclaimer

For laboratory and scientific research use only. ( Synedica Retatrutide 40mg + KLOW Skin 80mg Bundle)

Not intended for human consumption, therapeutic use, diagnosis, treatment, or prevention of disease.

What is Included in the Synedica Retatrutide 40mg + KLOW Skin 80mg Bundle ?

The bundle combines a 40mg Synedica Retatrutide Pen with an 80mg Synedica KLOW Skin Pen. The KLOW Skin formulation contains 48mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV and 2mg Vitamin B12, providing 120mg of combined labelled content across the two products.